Clinical Trial Update: Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for weekly Utidelone in HER2-negative inoperable locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Utidelone (utidelone)

Snippet

Sponsor: Fudan University | Conditions: Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN